期刊文献+

遗传因素蛋白C活性与CYP2C19基因在DVT患者血清中的表达及其意义

The protein C activity and cytochrome P4502C19(CYP2C19) gene expression in the patients with acute deep vein thrombosis(DVT)
下载PDF
导出
摘要 目的研究急性深静脉血栓(DVT)患者外周血中蛋白C活性,及细胞色素P4502C19(CYP2C19)基因表达情况,探讨在DVT患者中蛋白C系统与CYP2C19表达之间的关系,了解这两种遗传性因素在DVT患者发病过程中所起作用及其重要性。方法检测213例DVT患者外周血蛋白C活性及CYP2C19基因表达,掌握遗传性蛋白C缺陷症、CYP2C19基因突变对DVT发病影响及重要性。结果与126例对照组相比,骨折、外伤、其他手术史的DVT组的患者蛋白C活性原发性降低,差异具有统计学意义(P<0.05);CYP2C19基因变异型(中间代谢、慢代谢型)分布未见明显特点,差异无统计学意义。结论遗传性蛋白C缺陷对DVT发病起重要作用,CYP2C19基因对于DVT患者的治疗预后关系密切,但对于DVT发病作用未见明显特征。而蛋白C与CYP2C19基因表达在DVT患者中未见明显关联。 Objective To explore the protein C activity and cytochrome P4502C19 (CYP2C19) gene expression in the patients with acute deep vein thrombosis (DVT) to determine the relationship of these two genetic factors( protein C system and the expression of CYP2C19 ) with DVT and to study the role and importance on these both genetic factors in the pathogenesis of patients with DVT. Methods The protein C activity and expression of CYP2C19 gene were detected in 213 cases of DVT patients so as to mastering the hereditary protein C deficiency, CYP2C19 gene mutation affecting to the incidence and significance of DVT. Results The protein C activity decreased in the group of the patients with DVT with fractures, trauma, and surgical history primary decreased protein C activity compared with control group of 126 cases. The difference is statistically significant between two groups(P< 0.05). CYP2C19 gene variant including intermediary metabolism and slow metabolism had no significant distribution characteristic.The difference was not statistically signiifcant. Conclusion Hereditary protein C deifciencies plays an important role on the pathogenesis of the patients with DVT and CYP2C19 gene is also important for the prognosis of the patients with DVT. And no evidence showed that there’s relationship between the protein C and CYP2C19 gene expression in the patients with DVT.
出处 《临床普外科电子杂志》 2013年第4期17-20,共4页 Journal of General Surgery for Clinicians(Electronic Version)
关键词 深静脉血栓形成 遗传因素 蛋白C CYP2C19基因 Deep vein thrombosis Genetic factors Protein C CYP2C19 gene
  • 相关文献

参考文献8

  • 1潘以锋,孙敏莉,张皓,张柏根.深静脉血栓形成与凝血因子Ⅷ及蛋白C、蛋白S的相关性[J].中华实验外科杂志,2010,27(5):575-576. 被引量:19
  • 2D'Ursi P1,Orro A,Morra G. Molecular dynamics and docking simulation of a natural variant of Activated Protein C with impaired protease activity:implications for integrin-mediated antiseptic function[J].{H}Journal of Biomolecular Structure and Dynamics,2013,(13):364-367. 被引量:1
  • 3Muratsu J1,Morishima A,Mizoguchi K. Budd-Chiari Syndrome with Multiple Thrombi due to a Familial Arg42Ser Mutation in the Protein C Gene[J].Case Rep Med,2013,(10):270-274. 被引量:1
  • 4Mosnier LO,Fernández JA,Davis TP. Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of t-PA and of t-PA on the variant's anticoagulant activity[J].{H}Journal of Thrombosis and Haemostasis,2013,(11):2059-2062. 被引量:1
  • 5周健,吕虹,康熙雄.中国汉族人群不同性别、年龄、体重指数之间细胞色素氧化酶CYP2C19基因多态性的检测[J].中国临床药理学与治疗学,2007,12(2):208-213. 被引量:84
  • 6Holmes MV,Perel P,Shah T. CYP2C19 genotype,clopidogrel metabolism,platelet function,and cardiovascular events:a systematic review and meta-analysis[J].{H}JAMA:the Journal of the American Medical Association,2011,(24):2704-2714. 被引量:1
  • 7Aradi D,Rideg O,Vorobcsuk A. Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity[J].{H}European Journal of Clinical Investigation,2012,(04):384-392. 被引量:1
  • 8Alexopoulos D,Dimitropoulos G,Davlouros P. Prasugrel overcomes high on clopidogrel platelet reactivity post-stenting more effectively than high-dose(150mg)clopidogrel:the importance of CYP2C19*2 genotyping[J].JACC Cardiovasc Interv,2011,(04):403-410. 被引量:1

二级参考文献22

  • 1李洁,辛晓敏,刘娅娜.血浆蛋白C、蛋白S在静脉血栓病人诊断及治疗中的应用[J].微循环技术杂志(临床与实验),2004,8(5):317-317. 被引量:8
  • 2姜剑军,张柏根,张皓.中国汉族深静脉血栓形成患者与组织因子途径抑制物基因多态性的关系[J].中华实验外科杂志,2005,22(6):676-677. 被引量:3
  • 3Ferrari E,Baudouy M,Cerboni P,et al.Clinical epidemiology of venous thromboembolic disease.Results of a french multicentre registry.Eur Heart J,1997,18:685-691. 被引量:1
  • 4Mann KG.Biochemistry and physiology of blood coagulation.Thromb Haemost,1999,82:165-174. 被引量:1
  • 5Wroblewski B,Glenn MB.The cytochrome P450 drug metabolizing enzyme system:an overview of potential clinicially important drug interactions[J].J Head Trauma Rebabil,2002;17:571-574. 被引量:1
  • 6Wedlund PJ,Aslanian WS,McAllister CB,et al.Mephenytoin hydroxylation deficiency in Caucasians:frequency of a new oxidative drug metabolism polymorphism[J].Clin Pharmacol Ther,1984;36:773-780. 被引量:1
  • 7Wrighton SA,Stevens JC,Becker GW,et al.Isolation and characterization of human liver cytochrome P450 2C19:correlation between 2C19 and S-mephenytoin 4'-hydroxylation[J].Arch Biochem Biophys,1993;306:240-245. 被引量:1
  • 8He N,Yan FX,Huang SL,et al.CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population[J].Eur J Clin Pharmacol,2002;58:15-18. 被引量:1
  • 9Kimura M,Ieiri I,Mamiya K,et al.Genetic Polymorphism of Cytochrome P450s,CYP2C19,and CYP2C9 in a Japanese Population[J].Ther Drug Monit,1998;20:243-247. 被引量:1
  • 10Roh HK,Dahl ML,Tybring G,et al.CYP2C19 genotype and phenotype determined by omeprazole in a Korean population[J].Pharmacogenetics,1996;6:547-551. 被引量:1

共引文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部